Back

Temporal trends on percutaneous mitral commissurotomy: 30 years of experience

28 August 2018 (15:50 - 16:40)
Organised by:
Congress Presentation Part of: Outcome prediction tools after valve intervention Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Cyrielle Desnos

Hospital Tenon, Paris (France)

6 More presentations in this session

Presentation thumbnail
Impact of elixhauser comorbidity score on the outcomes of transcatheter aortic valve replacement
Doctor V. Nagaraja (Rochester, US)
Abstract Slides
Presentation thumbnail
Association of renin-angiotensin system inhibition with clinical outcomes in patients undergoing transcatheter aortic valve replacement: analysis from the STS/ACC TVT Registry
Doctor T. Inohara (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Prevalence and prognostic impact of prosthesis-patient mismatch after transcatheter aortic valve implantation
Doctor N. Schofer (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Development of immediate and late predictor score of success after percutaneous mitral valvoplasty in patients with mitral stenosis
Doctor J. Costa Jr (Sao Paulo, BR)
Presentation thumbnail
Prognostic value of logistic EuroSCORE and STS-PROM in a recent patient cohort undergoing TAVI with next generation transcatheter heart valves
Mr B. Al-Kassou (Bonn, DE)
Abstract Slides

Access the full session

Session thumbnail
Outcome prediction tools after valve intervention

The Event

Event poster

ESC Congress 2018

28 August 2018 15:50 CET
You may be interested in
thumbnail
Congress Presentation
Percutaneous valve commissurotomy in mitral stenosis patients: a 20 years follow-up
28 August 2022
thumbnail
Webinar
Mitral valve regurgitation management: what is new?
2 February 2022
thumbnail
Congress Presentation
Temporal trends in mitral valve surgery in Denmark: changes in patient characteristics and outcomes from 1996 to 2021
2 September 2024
thumbnail
Congress Presentation
Acute and chronic changes in LV performance in patients with primary severe mitral regurgitation undergoing percutaneous mitral valve repair
9 December 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources